Nisa Investment Advisors’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Nisa Investment Advisors’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,369	Closed	-$47.9K	–	3020
2024 Q1	$47.9K	Buy	1,369 +26	+2%	+$948	﹤0.01%	1663
2023 Q4	$51K	Hold	1,343	–	–	﹤0.01%	1632
2023 Q3	$24.6K	Sell	1,343 -997	-43%	-$20.9K	﹤0.01%	1947
2023 Q2	$60.7K	Buy	2,340 +13	+0.6%	+$304	﹤0.01%	1681
2023 Q1	$44K	Sell	2,327 -19	-0.8%	-$442	﹤0.01%	1758
2022 Q4	$58K	Hold	2,346	–	–	﹤0.01%	1724
2022 Q3	$47K	Buy	2,346 +2,026	+633%	+$36.5K	﹤0.01%	1761
2022 Q2	$4K	Sell	320 -10,800	-97%	-$159K	﹤0.01%	2306
2022 Q1	$248K	Buy	11,120 +10,120	+1,012%	+$258K	﹤0.01%	1296
2021 Q4	$27K	Buy	+1,000	New	+$40K	﹤0.01%	1874

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Nisa Investment Advisors's INBX Position: Q2 2024 in Review

Nisa Investment Advisors sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 1,369 shares — an estimated $47.9K sold.

Nisa Investment Advisors first reported a position in INBX in Q4 2021 and held it in 10 quarters. The position peaked at $248K in Q1 2022. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Nisa Investment Advisors reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Nisa Investment Advisors sold 1,369 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $47.9K.
Nisa Investment Advisors first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
Nisa Investment Advisors's Inhibrx, Inc. Common Stock position peaked at $248K in Q1 2022.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Nisa Investment Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.